MyMyelomaTeam

MGUS stands for Monoclonal Gammopathy of Undetermined Significance. It's a blood disorder where abnormal plasma cells produce an unusual protein called M protein. It's not cancer, but it's considered a precursor condition that can, in some cases, progress to myeloma. Here are some key things to know about MGUS:

- Most Show Full Answer

MGUS stands for Monoclonal Gammopathy of Undetermined Significance. It's a blood disorder where abnormal plasma cells produce an unusual protein called M protein. It's not cancer, but it's considered a precursor condition that can, in some cases, progress to myeloma. Here are some key things to know about MGUS:

- Most people have no symptoms — it's often found accidentally during routine blood tests
- It's fairly common — around 2–3% of people over 50 have it, rising to 5% in those over 70
- Progression risk is low — only about 1% of people with MGUS per year go on to develop myeloma
- Regular monitoring is important — blood and urine tests every 6–12 months help track any changes
- Risk levels vary — doctors classify MGUS as low, intermediate, or high risk based on test results If MGUS is detected, the usual approach is "watchful waiting" rather than immediate treatment. Staying on top of regular check-ups is the best way to catch any changes early.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

MGUS vs. Multiple Myeloma: What’s the Difference? (VIDEO)

Multiple Myeloma Types and Related Conditions